Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 10/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21489595 | 1.00 | PNMT (0.53) | PNMTADRA2ACHRM2CHRM4CHRM5 | |
| SCHEMBL16267716 | 1.00 | PNMT (0.53) | PNMTADRA2ACHRM2CHRM4CHRM5 | |
| SCHEMBL21496903 | 0.89 | PNMT (0.44) | PNMTADRA2ACHRM2CHRM4CHRM5 | |
| Trifluoroacetic Acid SCHEMBL25291317 | 0.88 | PNMT (0.43) | PNMTADRA2A | |
| SCHEMBL16271249 | 0.80 | PNMT (0.37) | PNMTADRA2ACHRM2CHRM4CHRM5 | |
| SCHEMBL894205 | 0.75 | PNMT (0.67) | PNMTADRA2A | |
| SCHEMBL29743356 | 0.75 | PNMT (0.67) | PNMTADRA2A | |
| SCHEMBL4738129 | 0.75 | PNMT (0.67) | PNMTADRA2A | |
| SCHEMBL894207 | 0.75 | PNMT (0.67) | PNMTADRA2A | |
| SCHEMBL29570471 | 0.75 | PNMT (0.67) | PNMTADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111971282-B | Pyrazolotetrahydroisoquinoline derivatives as dopamine D1 receptor positive modulators | 伊莱利利公司 | 2024-03-19 | — | — | CN | disclosed |
| EP-4267555-A1 | OCTAHYDROISOQUINOLINYL DERIVATIVES | UCB Biopharma SRL (BE) | 2023-11-01 | — | — | EP | disclosed |
| EP-4263517-A1 | A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1 POSITIVE ALLOSTERIC MODULATOR | UCB Biopharma SRL (BE) | 2023-10-25 | — | — | EP | disclosed |
| EP-4263522-A1 | DIHYDROISOQUINOLINYL DERIVATIVES | UCB Biopharma SRL (BE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022129268-A1 | A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1 POSITIVE ALLOSTERIC MODULATOR | UCB Biopharma SRL (BE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129303-A1 | DIHYDROISOQUINOLINYL DERIVATIVES | UCB Biopharma SRL (BE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022117678-A1 | OCTAHYDROISOQUINOLINYL DERIVATIVES | UCB Biopharma SRL (BE) | 2022-06-09 | — | — | WO | disclosed |
| EP-3993794-A1 | A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1 POSITIVE ALLOSTERIC MODULATOR | UCB Biopharma SRL (BE) | 2022-05-11 | — | — | EP | disclosed |